Cost Savings Reinvestment Program

Program Description

The Department of Neurology & Neurological Sciences strives to deliver high-value care. This involves continuously improving the quality and safety of care, and also reducing costs where possible. The Cost Savings Reinvestment Program (CSRP) is a program that benefits both the School of Medicine and Stanford Health Care by sharing some of the realized cost savings from physician-led improvements. Although these funds cannot be used as any form of salary support or compensation for physicians, they can be used at the discretion of the departments to fund the purchase of supplies, research, or continuing education. Associate Chief Medical Office Dr. Paul Maggio administers this program.

For Neurology faculty members who wish to learn more about CSRP, please contact Carl Gold.

Cost-Conscious Attending Rounds Checklist

Cost-Conscious Attending Rounds Checklist

This project focused on providing appropriate care to hospitalized neurology patients by reducing low-value practices, like unnecessary telemetry, recurring labs, and administering IV medications in patients who can take pills. The main intervention was a rounding checklist completed for every patient every day on the Neurohospitalist and Stroke services. Led by Drs. Carl Gold, Katie Kvam, and Neil Schwartz, this project involved getting engagement from ten faculty members, all of the neurology residents, and dozens of rotating interns and medical students. The cost savings have been considerable, care has been more appropriate, and the checklist has been used daily since its implementation in 2017. This was Neurology’s first CSRP project.

Annual Grand Rounds in High-Value Care

Some of the cost savings from the “Cost-conscious attending rounds checklist” will be applied towards an honorarium for an annual Neurology Grand Rounds presentation from a national leader in high-value care. The first speaker in this series will be Dr. Christopher Moriates. Dr. Moriates is the Assistant Dean for Health Care Value at the University of Texas at Austin Medical School and the Executive Director of Costs of Care. Dr. Moriates will visit Stanford Neurology on Friday, February 28, 2020.

Advancing Care for Patients with Intracerebral Hemorrhage

Clinicians in the neurocritical care unit recognized that some patients with intracerebral hemorrhage remain in the ICU due to intravenous antihypertensive medications. Drs. Zachary Threlkeld and Karen Hirsch designed a protocol for safe, earlier transition to oral antihypertensives. This has allowed many patients to leave the ICU earlier, advancing the timeline of their recovery. The reduction in ICU length of stay is associated with cost savings. This is Neurology’s second CSRP project.